SPAC Overview
Timeline Progress
About
A newly formed blank-check company that seeks to complete an initial business combination with an unidentified target. It intends to focus on biotechnology opportunities and finance a company developing important new therapies.
Investment Focus
Biopharmaceuticals
The terms and the filing trail behind Frazier Life Sciences Acquisition Corp. II
What the sponsor registered, what the deal actually priced at, and every 8-K that moved it — unit structure, sponsor promote, and the dated lifecycle events, each linked to its filing.
- Unit structure as registered and as priced — price, warrant coverage, rights, trust per unit
- Sponsor promote: founder shares and percentage, private-placement warrants, trust deposit
- The full 8-K lifecycle timeline, each event linked to its filing
- Price history across the unit, share and warrant tickers
- Follow it, and see it change on your watchlist
SPAC Team
Sponsors
Leadership
Underwriters
Extended Team Information
Frazier Life Sciences brings life-sciences venture and public-equity investing experience, including biopharmaceutical investments, company creation and drug-development expertise. Its leadership includes Albert Cha, Kevin Li, Fran Adams and Alexandra (“Ali”) Jackson, supported by independent directors Benjamin L. Palleiko, R. Scott Struthers and William C. Fairey.